A sweeping legislative change embedded within the 2025 federal reconciliation law is set to fundamentally reshape the financial landscape of American healthcare. By imposing stringent new caps on Medicaid State Directed Payments (SDPs)—the mechanisms through which states incentivize health plans to increase provider reimbursement—the federal government is poised to curb approximately $911 billion in spending over the next decade.
At the heart of this legislative shift is a pivot away from "average commercial rates" as a benchmark for Medicaid payments. As the policy takes full effect, an estimated $60 billion in federal funding currently flowing to hospitals through SDPs is expected to be reduced. This analysis explores the fiscal, operational, and clinical implications of this transition, which impacts at least 37 states and threatens to disrupt the financial stability of providers already operating on thin margins.
The Evolution of State Directed Payments (SDPs)
To understand the magnitude of this change, one must first understand the role of SDPs. While states are generally restricted from mandating how Managed Care Organizations (MCOs) pay their network providers, the Centers for Medicare and Medicaid Services (CMS) has historically allowed states to implement SDPs. These programs allow states to require MCOs to set minimum payment rates for specific services, effectively acting as a bridge to align Medicaid reimbursements more closely with the higher rates paid by private insurers.
For years, this strategy served as a primary lever for states to improve provider participation and ensure that Medicaid enrollees had access to high-quality care. By allowing states to peg these payments to "average commercial rates"—which are often double the Medicare rate—CMS enabled hospitals to subsidize the lower reimbursement levels typically associated with public insurance. However, the rapid proliferation of these programs, particularly following a 2024 rule that codified SDP usage, spurred significant pushback from federal budget hawks who argued that these payments had become a loophole for inflated federal spending.
Chronology of the Legislative Shift
The journey toward these new limits reflects a growing tension between state autonomy in healthcare administration and federal fiscal oversight.
- Pre-2024: States increasingly utilized SDPs as a workaround to supplement hospital revenues, often financing these initiatives through provider taxes or intergovernmental transfers (IGTs).
- May 2024: CMS finalized a rule that codified the use of SDPs, which led to a surge in state applications and a significant increase in federal outlays.
- 2025 Reconciliation Law: Faced with rising costs, Congress passed the 2025 reconciliation law, which explicitly restricted SDP payment ceilings.
- June 2025: CMS released a proposed rule to implement the new payment caps, officially moving the goalposts from "average commercial rates" to a standardized Medicare-based benchmark.
- January 2028 and Beyond: The new limits are scheduled for a phased implementation, with full compliance expected at varying intervals depending on state-specific approval cycles.
Data Analysis: The Magnitude of the Reduction
KFF’s analysis, which examined 131 "preprints" (the administrative forms states use to document their SDP proposals), paints a stark picture of the coming contraction.
The $60 billion in estimated federal spending reductions represents roughly 64% of total federal spending on SDPs and 77% of federal spending specifically allocated for hospital services. These figures are not, however, simple annual losses. Because the limits are being phased in, the immediate impact on hospital balance sheets will vary based on the specific contract cycles of each state.
Regional and State-Level Variance
The impact is not distributed evenly. Eight states—California, Illinois, Kentucky, Texas, North Carolina, Louisiana, Arizona, and Michigan—account for more than 50% of the projected reduction. California alone faces a potential reduction of $7.4 billion.
The variation in impact is dictated by the states’ existing "base payment" rates. In states where base Medicaid payments are low, the SDPs have historically done the "heavy lifting" to bring total reimbursement toward parity with private markets. In these regions, the reduction will be most acutely felt. Conversely, states with higher base payments or those that have not aggressively utilized commercial-rate benchmarks may see a less severe impact.
The "Benchmark" Controversy: Medicare vs. Commercial Rates
The 2025 law mandates that SDP payment rates cannot exceed 100% of the Medicare payment rate in states that expanded Medicaid, and 110% of the Medicare rate in non-expansion states.
This is a significant downgrade from the previous standard. Because commercial insurers often pay 200% or more of Medicare rates, moving to a 100-110% cap represents a massive contraction in potential revenue for hospitals. Critics of the new law argue that these caps do not account for the true cost of delivering care in modern clinical environments, which often far exceeds the standardized costs calculated by the Medicare program.
Official Responses and Policy Perspectives
The policy has generated a polarized response from healthcare stakeholders.
Proponents of the cuts argue that the previous system allowed for an unsustainable "shell game" where states used federal matching dollars to artificially inflate provider payments without achieving clear improvements in patient health outcomes. From this perspective, the reconciliation law restores fiscal discipline and prevents the exploitation of federal funds.
Hospital associations and state health officials have expressed deep concern. Many argue that the reduction will create a "fiscal cliff" for rural and safety-net hospitals. In a statement regarding the uncertainty of the new policy, several state Medicaid directors have noted that the lack of clear, uniform guidance on how to handle existing contracts has left them in a state of operational limbo, unable to plan effectively for the 2026-2028 budget cycles.
Implications for Healthcare Delivery
The implications for the American healthcare system are profound and potentially destabilizing.
1. The Safety-Net Vulnerability
Safety-net hospitals, which serve a disproportionately high number of Medicaid enrollees, are the most exposed to these changes. Unlike large, for-profit hospital systems that can absorb fluctuations in revenue through their commercial patient base, rural and inner-city hospitals rely heavily on supplemental Medicaid payments to keep their doors open. The reduction in SDP funding could force these facilities to shutter critical service lines, such as labor and delivery or emergency departments.
2. Provider Participation and Access
One of the primary justifications for the original SDP framework was to encourage private providers to accept Medicaid patients. By lowering the ceiling on these payments, there is a legitimate risk that provider networks will shrink. If reimbursement rates are perceived as insufficient, physicians and hospital systems may limit the number of Medicaid beneficiaries they accept, creating a two-tiered system of care access.
3. Behavioral Responses by States
States are already looking for ways to adapt. Some may attempt to increase base payment rates through legislative action, although this is limited by state budget constraints. Others may look toward "creative financing" or alternative quality-incentive programs that do not fall under the strict definition of an SDP. However, the oversight provided by the 2025 law and the accompanying CMS rules suggests that the federal government will be keeping a close watch on these efforts to ensure they do not become new vehicles for inflated spending.
Conclusion: A Period of Uncertainty
The transition to a Medicare-based cap for State Directed Payments marks the end of an era of expansive, state-driven Medicaid funding. While the $60 billion reduction is intended to bring fiscal sustainability to the Medicaid program, the human cost of this transition remains to be seen.
As states grapple with the phase-in of these limits, the focus will inevitably turn to the resilience of the hospital sector. The coming years will likely be characterized by intense negotiations between state Medicaid agencies, the federal government, and hospital systems as they attempt to balance the necessity of fiscal restraint with the moral and practical imperative of maintaining access to care for millions of vulnerable Americans.
The "data gaps" identified by KFF in their analysis—including the inability to access certain state addendums—suggest that even the government may not fully grasp the ripple effects of these changes. As the implementation proceeds, transparency in reporting and a commitment to monitoring clinical outcomes will be essential to ensuring that the drive for federal savings does not come at the expense of patient health.
About the Author
